CD8A and neoplasm: As BIBN4096 showed no effect when administered to nociceptor-ablated mice and did not affect cultured B16F10 cells or CD8+ T cell function in vitro (Extended Data Fig. 10n–t), we conclude that the anti-tumour property of BIBN4096 relies on the presence of active nociceptor neurons.